Cytodyn Inc (CYDY)

$0.35 +0.03 (8.84%)
Market Cap 438.32M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,982,600
Avg Vol 1,875,768
Day's Range N/A - N/A
Shares Out 1.37B
Stochastic %K 76%
Beta 1.15
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
PerfectGreen
PerfectGreen May. 13 at 12:34 PM
$CYDY little surprised we haven’t PR’d the patent yet. Palmer’s abstract should be 1 also. We remain violently
0 · Reply
calbucs
calbucs May. 13 at 12:21 PM
$CYDY The good news just keeps coming , we are close to launching here , would like to see .50 plus in the next few weeks
0 · Reply
BioHazardTrader
BioHazardTrader May. 13 at 11:35 AM
$CYDY they are probably asking for the data so they can act fast. Imagine what the conversations must be at the moment. Can you share the data with me first? Who are you going to tell first? Are you going to let us know all at the same time? Good stuff.. all in my opinion. Shirts going to be in a world of hurt if data goes as planned and maybe even before. Imo
1 · Reply
calbucs
calbucs May. 13 at 11:25 AM
$CYDY Violent repricing !! $10/$15/$20 . Any of those would be great , let’s see the rats scatter .
1 · Reply
bellaboos
bellaboos May. 13 at 11:22 AM
$CYDY VERY
0 · Reply
JimmyTheGreek69
JimmyTheGreek69 May. 13 at 11:19 AM
$CYDY this is interesting https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.wsj.com/health/pharma/roche-ceo-expects-pharma-portfolio-to-deliver-sales-growth-through-2030-128588c4&ved=2ahUKEwjOldP_kbaUAxVHKEQIHVEvBksQxfQBKAB6BAgGEAE&usg=AOvVaw38Smk8NeipkYeFSDad_plH
0 · Reply
BioHazardTrader
BioHazardTrader May. 13 at 11:07 AM
$CYDY let's reprice violently!! Let's get it GSK.
0 · Reply
HEDZUP
HEDZUP May. 13 at 10:37 AM
$CYDY
0 · Reply
BullishTexas
BullishTexas May. 13 at 10:34 AM
$CYDY I’m Hump Day bullish. 🍀🙏🏻➡️
0 · Reply
geetee12345
geetee12345 May. 13 at 10:11 AM
$CYDY GM Fam
0 · Reply
Latest News on CYDY
No data available.
PerfectGreen
PerfectGreen May. 13 at 12:34 PM
$CYDY little surprised we haven’t PR’d the patent yet. Palmer’s abstract should be 1 also. We remain violently
0 · Reply
calbucs
calbucs May. 13 at 12:21 PM
$CYDY The good news just keeps coming , we are close to launching here , would like to see .50 plus in the next few weeks
0 · Reply
BioHazardTrader
BioHazardTrader May. 13 at 11:35 AM
$CYDY they are probably asking for the data so they can act fast. Imagine what the conversations must be at the moment. Can you share the data with me first? Who are you going to tell first? Are you going to let us know all at the same time? Good stuff.. all in my opinion. Shirts going to be in a world of hurt if data goes as planned and maybe even before. Imo
1 · Reply
calbucs
calbucs May. 13 at 11:25 AM
$CYDY Violent repricing !! $10/$15/$20 . Any of those would be great , let’s see the rats scatter .
1 · Reply
bellaboos
bellaboos May. 13 at 11:22 AM
$CYDY VERY
0 · Reply
JimmyTheGreek69
JimmyTheGreek69 May. 13 at 11:19 AM
$CYDY this is interesting https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.wsj.com/health/pharma/roche-ceo-expects-pharma-portfolio-to-deliver-sales-growth-through-2030-128588c4&ved=2ahUKEwjOldP_kbaUAxVHKEQIHVEvBksQxfQBKAB6BAgGEAE&usg=AOvVaw38Smk8NeipkYeFSDad_plH
0 · Reply
BioHazardTrader
BioHazardTrader May. 13 at 11:07 AM
$CYDY let's reprice violently!! Let's get it GSK.
0 · Reply
HEDZUP
HEDZUP May. 13 at 10:37 AM
$CYDY
0 · Reply
BullishTexas
BullishTexas May. 13 at 10:34 AM
$CYDY I’m Hump Day bullish. 🍀🙏🏻➡️
0 · Reply
geetee12345
geetee12345 May. 13 at 10:11 AM
$CYDY GM Fam
0 · Reply
jvnpppl
jvnpppl May. 13 at 9:27 AM
$CYDY always be violently …
1 · Reply
GhostofCytomight
GhostofCytomight May. 13 at 6:26 AM
$CYDY LOVING THE SOUND OF THAT‼️”Groundbreaking cancer innovation”
0 · Reply
Livingeasy
Livingeasy May. 13 at 6:08 AM
$CYDY 🦢https://www.walshmedicalmedia.com/open-access/leronlimab-a-humanized-anticcr5-monoclonal-antibody-ameliorates-hepatic-fibrosis-in-two-preclinical-fibrosis-mouse-model.pdf
0 · Reply
Livingeasy
Livingeasy May. 13 at 6:00 AM
$CYDY 🙈🙉🙊! 🐒
0 · Reply
PerfectGreen
PerfectGreen May. 13 at 5:50 AM
$CYDY
1 · Reply
Buyout_offer
Buyout_offer May. 13 at 5:05 AM
$CYDY Very Bullish!
1 · Reply
Buyout_offer
Buyout_offer May. 13 at 5:04 AM
$CYDY CYDY is long overdue to move above .38 as base price. With all the positive test data currently presented, there is no reason big pharmaceutical companies would not be ready to buyout the company for billions! The days of 30 cents will seem hard to believe as that scenario gets closer. But until the picture is clearer the share price will fluctuate under those suppressing the price.
0 · Reply
dontfeedthebashers
dontfeedthebashers May. 13 at 4:44 AM
$CYDY now tell it to disprove the circle jerk
2 · Reply
u2rocksme
u2rocksme May. 13 at 2:55 AM
$CYDY BULLISH!!! SAFE AND EXTREMELY EFFECTIVE LERONLIMAB SAVES LIVES!!!
0 · Reply
BullishTexas
BullishTexas May. 13 at 2:15 AM
$CYDY My favorite quote from a chat with chat, which started with a basic assessment of Dr. Palmer's publication just shared by @Bio4. "If the upcoming ~60-patient dataset genuinely confirms: - durable survival outperformance, - meaningful TME remodeling, - biomarker coherence, - checkpoint enhancement, - and outcomes materially beyond expected standards of care, then the market reaction for CytoDyn could be exceptionally large relative to its current valuation. Not because the company would instantly become “de-risked” — it would not — but because: the market would suddenly need to reprice the probability that LL is a real oncology platform asset. That repricing could be violent." "That repricing could be violent." 🍀🙏💥🚀➡️
3 · Reply
MOneyMoney111
MOneyMoney111 May. 13 at 2:04 AM
$CYDY 🙂
1 · Reply
Twinter11
Twinter11 May. 13 at 1:00 AM
$CYDY "How the "JV Silo" Strategy Defeats "Chicken Feed" Offers: No "Hostile" Takeover: By splitting into silos, too complex for one company to just "buy and bury." Compounding Upfronts: Instead of one $500M upfront, CytoDyn collects three separate upfronts for the same molecule. Retained Royalties: Even after paying the two 5% "legacy" royalties, CytoDyn (the parent) becomes a Cash Flow Machine, collecting billions in net royalties to fund its own future R&D. The "Undeniable" Reality: You are looking at a $100B+ total platform.Lalezari's "quiet" strategy and the MD Anderson/City of Hope signatures are the "due diligence" that prevents a lowball offer. They are building a case that leronlimab is the foundational biologic of the 21st century. the MD Anderson/City of Hope signatures are the "due diligence" that prevents a lowball offer. They are building a case that leronlimab is the foundational biologic of the 21st century
1 · Reply